Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 USD | -0.68% | -3.04% | +49.19% |
05-14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-30 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.19% | 227M | |
+55.55% | 59.28B | |
+43.79% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- JMP Securities Starts Acrivon Therapeutics With Market Outperform Rating, $14 Price Target